Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Autophagy and its role in protective and damaging inflammatory response].
Heat shock protein 27 in multiple sclerosis relapses.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
The role of microglial activation in disease progression.
The pathology of multiple sclerosis.
Merck KGaA Reaches Mutual Agreement with Ono Pharmaceutical to Terminate the License Agreement on Ceralifimod (ONO-4641)
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
Acid-sensing ion channels: trafficking and synaptic function.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
Natalizumab discontinuation and disease restart in pregnancy: a case series.
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Navigating Life and Loss in Pediatric Multiple Sclerosis.
Pages
« first
‹ previous
…
171
172
173
174
175
176
177
178
179
…
next ›
last »